Therapeutic Efficiency of an External Chinese Herbal Formula of Mammary Precancerous Lesions by BATMAN-TCM Online Bioinformatics Analysis Tool and Experimental Validation

Figure 6

Relative mRNA expression of ESR1(a), PGR(b), EGFR(c), PTGS2(d), and Src(e) at 24h after vehicle, TAM, or various concentrations of RYNXT treatment in MCF-10AT cells. P<0.05, RYNXT (2%, 4%), TAM, or Veh group versus control group; ^▲P<0.05, RYNXT (2%, 4%), TAM, or control group versus Veh group. Data are representative of 3 independent experiments.

(a)

(b)

(c)

(d)

(e)